Latest news
Loading news…
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.
Aliada Therapeutics was acquired by AbbVie in 2024 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
11
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Boston, Massachusetts, United States
11
professional contacts at Aliada Therapeutics
Contact execs at Aliada Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Aliada Therapeutics
Loading news…
FAQs about Aliada Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.